Proteomics

Dataset Information

0

Extended coverage of human serum glycosphingolipidome by 4D-RP-LC TIMS-PASEF unravels association with Parkinson's disease


ABSTRACT: Glycosphingolipids (GSLs) are important targets in immune, infectious, lysosomal storage diseases, cancer, and neurodegenerative diseases. Circulatory GSL profiling in clinical samples is restricted by the lack of mid- and high-throughput analytical methods and deep coverage of long-chain sialylated glycosphingolipidome. We present a 4-dimensional (4D)-glycosphingolipidomics platform for routine glycosphingolipidome profiling encompassing: extraction and fractionation of sialylated GSLs with 3 to 15 monosaccharides, neutral GSLs and sulfatides; µL-flow reversed-phase LC-TIMS-PASEF MS analysis; semi-quantification strategy adapted for fractionated glycosphingolipidome, and referential CCS, RT, and m/z values for GSL annotation. 4D-glycosphingolipidomics of human serum reveals a high structural heterogeneity, amounting to 376 GSLs: 159 GSLs of ganglio- and neolacto-series, 145 neutral GSLs and 72 sulfatides. Here we demonstrate the platform’s utility for clinical profiling of Parkinson’s disease (PD) sera. 41 neolacto- and ganglio-species discriminate PD patients from controls and 14 GSLs differentiate sex subgroups, laying the foundation for further functional GSL studies with PD.

INSTRUMENT(S): timsTOF Pro, timsTOF fleX

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Laura Bindila  

PROVIDER: MSV000097015 | MassIVE | Fri Jan 31 08:56:00 GMT 2025

REPOSITORIES: MassIVE

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-12-07 | ST002402 | MetabolomicsWorkbench
2023-02-28 | PXD035249 | Pride
2020-04-23 | PXD014777 | Pride
2024-06-25 | GSE231547 | GEO
2024-05-01 | GSE264103 | GEO
2016-08-25 | PXD004289 | Pride
2016-06-07 | E-MTAB-4586 | biostudies-arrayexpress
2022-02-16 | PXD021960 | Pride
2008-11-22 | E-GEOD-6613 | biostudies-arrayexpress
2019-03-19 | GSE125871 | GEO